Avatar

What Is the COVID-19 Cancer Consortium? Urgent Need to Generate Knowledge Regarding COVID-19

By Petros Grivas 7 Videos
April 18, 2020
2 Comments
Login to view comments. Click here to Login

Featured Video

12:13
Lilly

Efficacy of a Treatment in Combination With Endocrine-Based Therapy

Feat. M. Dietrich

Featured Video

45:38
Novartis Oncology

A Discussion of PIK3CA Mutations in HR+/HER2- Advanced Breast Cancer

Feat. S. Donahue, N. Oncology, H. Rugo

Related Content

AUTOPLAY
21:42
UAB Hematology Review 2021

Hematologic Manifestations of COVID-19: Thrombosis Mechanisms and Risk, CO…

Feat. R. Gangaraju
33:24
Zahra Pakbaz

Current Approach to Sickle Cell Anemia: COVID & SCD, Genotypes, Hemoly…

12:10
Penn Medicine Abramson Cancer Center

2021 Updates in Medical Oncology for Lung Cancer: Targeted Therapy, Tumor …

Feat. C. Aggarwal
10:25
Houston Methodist DeBakey Heart and Vascular Center

COVID-19 & Cytokine Storm: What Kind of Inflammatory Markers Are Released …

Feat. J. Chang
09:15
8th Eurasian Hematology Oncology Summit

How I Treat ET in 2021: WHO True-ET, Thromboembolic/Bleeding Complications…

Feat. D. Wolf
13:34
UAB Hematology Review 2021

CLL Management in Times of COVID-19: Frontline Acalabrutinib or Ven +/- Ob…

Feat. M. Narkhede
15:32
Penn Medicine Abramson Cancer Center

COVID-19 Vaccination Guidelines for Our Cancer Patients: What Are the Elig…

Feat. L. Schuchter
21:47
Total Health Conferencing

Shared Expert Experience on the CML Management in the Time of COVID-19: Ho…

Feat. T. Kadia, F. Santos, H. Malhotra
47:07
Penn Medicine Abramson Cancer Center

Updates on Breast Care and Imaging During COVID-19: Vaccine-Related Axilla…

Feat. R. Jankowitz, E. Conant, T. D'Entremont, A. Steiner, J. Tchou
16:58
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

Lessons Learned From irAE Management During COVID-19: Cytokine Storm, Impl…

Feat. L. Calabrese
15:18
Memorial Sloan Kettering Cancer Center

MSKCC Updates on Telemedicine/Cohort Monitoring & COVID-19 Testing for Che…

Feat. D. Reidy-Lagunes
33:00
Total Health Conferencing

Will COVID-19 Leave Its Mark on Cancer Care?

Feat. G. Lopes
15:40
ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases

COVID-19 & Hematologic Malignancies: What Is the Mortality Estimate Per Ma…

Feat. J. Leal
17:35
ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases

COVID-19 Coagulopathy: What Is Virchow’s Triad? What Are the VTE Rates in …

Feat. P. Harris
13:17
Penn Medicine Abramson Cancer Center

Penn Updates on RT in Lung Cancer During COVID-19: SBRT vs. Surgery, Antim…

Feat. A. Berman
12:50
Moffitt Cancer Center

Melanoma Drug Therapy During COVID-19: When to Wait or Go Forward With the…

Feat. Z. Eroglu, V. Sondak
15:18
Penn Medicine Abramson Cancer Center

Penn Medicine Melanoma Management During COVID-19: What Are the Main Conce…

Feat. E. Chu, R. Bronfenbrener, C. J. Miller
18:31
ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases

COVID-19 Therapeutics: Remdesivir/Bamlanivimab/Casirivimab+Imdevimab - Wha…

Feat. K. Konrardy
10:01
Moffitt Cancer Center

COVID-19 in Lung Cancer Patients: Does Chemotherapy Increase the Severity …

Feat. M. Shafique
11:47
Fox Chase Cancer Center's Genitourinary Malignancies in the Time of COVID-19

Fox Chase Experience on COVID-19 & Cancer: Disease Biology, Risks of Syste…

Feat. A. Kutikov